Anterior T-wave inversion (TWI) is a recognized variant in athletes of African/Afro Caribbean origin and some endurance athletes; however, the presence of this specific repolarization anomaly also raises the possibility of cardiomyopathy. The differentiation between physiological adaptation and cardiomyopathy may be facilitated by examining other repolarization parameters, notably the J-point and the ST-segment.
Introduction
Anterior (V1-V4) T-wave inversion (TWI) on an athlete's 12-lead electrocardiogram (ECG) is often considered an abnormal finding and warrants thorough clinical investigation to exclude diseases frequently implicated in exercise-related sudden cardiac death (SCD), notably the cardiomyopathies. 1 -3 Anterior TWI is detected in 2 -4% of patients with hypertrophic cardiomyopathy (HCM) 4 but may be present in as many as 80% of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). 5 -8 However, anterior TWI is also observed on the ECG of healthy athletes, with a reported prevalence of 2 -7% in the general population of Caucasian (white) athletes, 4, 6, 9 12 -13% in African/Caribbean (black) athletes, 4 ,10 and 14 -28% in the subgroup of endurance athletes of mixed ethnicity. 11 -12 Previous studies comparing the prevalence of anterior TWI in black athletes and black patients with HCM suggest that TWI limited to V1 -V4 and preceded by convex ST-segment elevation is likely to represent an ethnic variant of the 'athlete's heart'. 4, 10 The recently published Seattle criteria recommend that anterior TWI preceded by a convex ST-segment elevation in black athletes does not require further assessment to exclude a cardiomyopathy in the absence of symptoms, a positive family history, or an abnormal physical examination. 2 Although this approach offers the potential to lower the high burden of falsepositive ECG rates traditionally observed in the black athletic population, 11 -16 the diagnostic accuracy of this ECG criterion has not been validated quantitatively. A further unresolved issue is whether the Seattle recommendation is also applicable to white athletes, considering that there are emerging reports that up to 8% of white endurance athletes show anterior TWI.
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The present study compared several qualitative and quantitative electrocardiographic features in healthy athletes and patients with HCM and ARVC of both black and white ethnicity who showed TWI in the anterior leads. The aim was to identify co-existing ECG parameters that may help to differentiate physiological anterior TWI from pathological anterior TWI.
Methods

Study population
This study compared three different cohorts of subjects, each containing individuals of both white and black ethnicity, as follows: (i) 80 healthy competitive athletes; (ii) 95 patients with HCM, including 26 affected athletes; and (iii) 58 patients with ARVC, including 9 affected athletes. For each group, the criterion for inclusion into the study was the presence of TWI of ≥1 mm in at least two contiguous anterior leads (V1 to V4), in the absence of right or left bundle branch block (LBBB) and regardless of the presence or absence of TWI in the other leads. In the group of healthy athletes, the ECG used for analysis was acquired at the time of the last pre-participation evaluation. Among non-athlete patients with cardiomyopathy, the ECG used for analysis was recorded during the last follow-up visit. For athletes diagnosed with a cardiomyopathy, we used the ECG performed during pre-participation evaluation that led to the diagnosis of cardiomyopathy following subsequent investigation. The study population consisted of consecutive patients and athletes detected with anterior TWI between 2010 and 2012 in three collaborative centres: the Inherited Arrhythmogenic Cardiomyopathy Unit of the Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Italy (white patients with HCM, either nonathletes and athletes; white and black patients with ARVC, either nonathletes and athletes); the Division of Cardiovascular Sciences, St George's University of London, UK (white athletes with HCM, black healthy athletes and black patients, either athletes or non-athletes, with HCM); and the Center for Sport Medicine and Science (CONI), Rome, Italy (white healthy athletes).
Healthy athletes
All athletes underwent detailed clinical evaluation to rule out underlying cardiac disease, including family and personal history, physical examination, basal and exercise ECG, 24-h Holter monitoring, and echocardiography. Athletes with a previous history of cardiac or pulmonary disease, systemic hypertension, diabetes mellitus, family history of cardiomyopathy, or family history of premature (≤40 years) SCD were excluded from the study. Athletes with electrocardiographic evidence of ventricular pre-excitation or complete bundle branch block were also excluded. Sports activity was classified according to the two general types of exercise (dynamic and static), based on the Mitchell classification. 17 Contrast-enhanced cardiac magnetic resonance imaging was reserved for selected cases with findings suspicious of an underlying cardiomyopathy, including (i) athletes exhibiting 'grey zone' left ventricular (LV) hypertrophy on echocardiography, suspicious of mild HCM and (ii) athletes with right ventricular (RV) structural or functional abnormalities or arrhythmias of RV origin, suspicious of ARVC. The differential diagnosis between athlete's heart and cardiomyopathy was based on current criteria. 18 
Hypertrophic cardiomyopathy patients
The diagnosis of HCM was based upon a maximal LV wall thickness of ≥15 mm in end-diastole in the absence of a cardiac or systemic cause capable of producing the same degree of hypertrophy or a maximal wall thickness of 13 -15 mm in the context of ECG repolarization anomalies and a family history of HCM in a first-degree relative or positive genotype, in the absence of a cardiac or systemic cause capable of producing the same degree of hypertrophy. 19 In the 26 athletes with HCM, the ECG was obtained during pre-participation screening and led to a diagnosis at a time when they were still actively involved in competitive sporting activity.
Arrhythmogenic right ventricular cardiomyopathy patients
All ARVC patients had an established diagnosis of ARVC in accordance with the 2010 Revised Task Force diagnostic criteria and fulfilled two major criteria, one major criterion, and two minor criteria or four minor criteria, as reported elsewhere. 20 Patients with a diagnosis of 'borderline' or 'possible' ARVC were excluded from the study. As with athletes with HCM, the ECG in 9 athletes with ARVC was obtained at the time of pre-participation screening.
Electrocardiography
Electrocardiography was performed using conventional methods, with the subject in supine position and acquisition taken during quite respiration with a recording speed of 25 mm/s and 10 mm/1 mV calibration. For digital analysis, hard copies of the ECGs were scanned on a flatbed scanner at a resolution of 300 dpi. Electrocardiogram measurement with digital callipers and interpretation was performed independently by two observers (C.C. and A.Z.) who were blinded to the disease status. In cases of disagreement, consensus was obtained from a third observer who is a highly qualified electrophysiologist and an expert in cardiomyopathies (D.C.).
Standard measurements included heart rate; rhythm; PR interval; QRS axis, voltage, and duration; ST-T-wave abnormalities and pathological Q-waves. Electrocardiogram abnormalities were defined as follows: (i) voltage criteria for LV hypertrophy according to the Sokolow-Lyon index (SV 1 + RV 5 or RV 6 , whichever is larger, .35 mm); (ii) pathologic Q-waves as .0.04 s in duration and/or .25% of the ensuing R-wave in depth in at least two leads (except III, aVR, and V1); (iii) pathological ST-segment depression as ST-depression of .1 mm in depth in at least two adjacent leads; (iv) abnormal TWI as TWI ≥1 mm in at least two adjacent leads (except aVR, V 1 , and III), in the absence of conduction disturbance; (v) max TWI ≥5 mm as maximum amplitude of negative T-wave ≥5 mm in any lead (except aVR, V 1 , and III); (vi) left atrial enlargement as a negative portion of the P-wave in lead V 1 ≥1 mm in depth and ≥0.04 s in duration; (vii) complete right bundle branch block (RBBB) as a RSR' pattern in V1 where R' . R and a slurred S-wave in leads I and V6 with a QRS duration of ≥0.12 s; (viii) complete LBBB as a QS or rS complex in lead V1 and a RsR' wave in lead V6 with QRS duration of ≥0.12 s; (ix) frontal-plane left QRS axis deviation as 2308 to 2908.
The following quantitative ECG parameters of ventricular repolarization were measured: (i) the extent of TWI across the precordial leads; (ii) the maximum J-point elevation in the anterior leads (V1 -V4) exhibiting TWI; (iii) the maximum ST-segment elevation in the anterior leads exhibiting TWI; (iv) the maximum depth of anterior T-wave negativity under the isoelectric line; and (v) the maximum corrected QT interval (QTc) calculated using Bazett's formula. As previously described in detail, 21 when the end of the QRS complex was difficult to define because of a gradual slope towards the ST-segment, the J-point was extrapolated as the point at which the ST-segment intersected the tangent of the slope of QRS terminal part extended upward.
Statistical analysis
Continuous variables were expressed as mean and standard deviation or median and inter-quartile range (IQR) for normally and nonnormally distributed variables, respectively. Group differences were compared using the Student' t-test or Wilcoxon rank sum test for normally and non-normally distributed variables, respectively. Categorical variables were expressed as absolute numbers (n) and percentages (%), and compared with the x 2 test or the Fisher exact test, as appropriate. Univariate and multiple binary logistic regression analysis was used to determine which of the following variables predicted a cardiomyopathy: (i) J-point elevation ≤1 mm in at least one anterior lead (V1 -V4) exhibiting TWI; (ii) ST-segment elevation ≤1 mm in at least one anterior lead exhibiting TWI; (iii) Max TWI ≥5 mm; and (iv) TWI extending beyond V4 to the lateral (V5 -V6, I, aVL) and/or also involving the inferior (II, III, aVF) ECG leads. Variables with a P-value of ,0.15 at univariate regression analysis were selected for multiple regression analysis. Two different models were built: one unadjusted and one adjusted for age, gender, and ethnicity. Positive and negative predictive values for anterior TWI in the setting of pre-participation screening were calculated according to the estimated prevalence of HCM and ARVC among athletes with anterior TWI. The prevalence of HCM in athletes is 0.06%, 22 but only 2% of athletes with HCM show anterior TWI; 16 hence, the prevalence of athletes with HCM who have anterior TWI is 0.06 × 2% ¼ 0.0012%. In our population of mixed ethnicity, 8% 16 of athletes show anterior TWI; therefore, the estimated number of athletes with HCM and anterior TWI was 0.0012/8% ¼ 0.015%. The prevalence of ARVC in screened athletes is 0.03%. 23 The prevalence of anterior TWI among individuals with ARVC is 50%; 7 hence, the number of athletes with ARVC who exhibit anterior TWI is 0.03 × 50% ¼ 0.015%. In our population of mixed ethnicity, 8% 16 of athletes show anterior TWI; therefore, the estimated number of athletes with ARVC and anterior TWI was 0.015/ 8% ¼ 0.2%. Ninety-five per cent confidence interval (CI) of sensitivity, specificity, and negative and predictive values were calculated based on the binomial distribution. All P-values reported are two-sided, and ,0.05 was considered statistically significant. Data were analysed with SPSS 17 (SPSS Inc., Chicago, IL, USA).
Results
Demographics and baseline clinical characteristics Healthy athletes
The median age of athletes was 21 years (IQR 16 -27, range 14 -37).
The majority (75%) were male and of black ethnicity (66%) (see Supplementary material online, Table S1 ). Seventy-seven athletes (98%) were engaged in sport disciplines with moderate or high static and dynamic components (IIB, IIC, IIIB, and IIIC). All athletes trained for at least 6 h per week and competed at regional, national, or international level. None reported symptoms indicative of cardiovascular disease or showed uncommon/non-training-related ECG abnormalities, except for TWI. At echocardiography, the median septum wall thickness was 11 mm (IQR 9 -12), the LV end-diastolic diameter 51 mm (IQR 40 -57), and the posterior LV wall thickness 10 mm (IQR 8 -11). The mean LV mass was 183 + 65 g, and the mean LV mass index was 97 + 38 g/m 2 . Mild RV dilation in the absence of regional or global systolic dysfunction was observed in 63 (79%) athletes.
Hypertrophic cardiomyopathy patients
Hypertrophic cardiomyopathy patients had a median age of 46 years (IQR 29 -56 years, range 14 -62). The majority were males (75%) and of white ethnicity (56%). At echocardiography, the septal wall thickness was 19 mm (IQR 17-33), LV end-diastolic diameter was 44 mm (35 -52), and the posterior LV wall thickness was 12 mm (IQR 11 -16). The median LV mass was 222 g (IQR 154 -298), and the median LV mass index was 123 g/m 2 (91-152).
Arrhythmogenic right ventricular cardiomyopathy patients Arrhythmogenic right ventricular cardiomyopathy patients had a median age of 32 years (IQR 19 -42 years, range 13 -53). The majority were males (71%) and of white ethnicity (95%). At echocardiography, median RV end-diastolic area was 29 cm 2 (IQR 26 -35 cm 2 ), and median RV fractional area change was 32% (IQR 28 -36%). Regional RV wall motion abnormalities were found in 53 patients (91%). Eleven patients (19%) showed LV involvement, with regional or global LV systolic dysfunction.
Comparison of electrocardiogram findings between healthy athletes and hypertrophic cardiomyopathy patients
Electrocardiogram findings in healthy athletes and HCM patients are shown in Table 1 . Compared with HCM patients, athletes more frequently exhibited J-point elevation ≥1 mm in at least one anterior lead with a negative T-wave (80 vs. 8%, P , 0.001), ST-segment Anterior T-wave inversion in athlete's heart vs. cardiomyopathy elevation ≥1 mm in at least one anterior lead with a negative T-wave (83 vs. 40%, P , 0.001), and TWI confined to leads V1 -V4 (71 vs. 3%, P , 0.001) (Figure 1 ). In contrast, HCM patients more frequently exhibited max TWI ≥5 mm (57 vs. 19%, P , 0.001) and TWI extending to the lateral (V5 -V6, I, aVL) and/or involving the inferior (II, III, aVF) leads (Figure 2) .
At multiple regression analysis, after adjustment for age, gender, and ethnicity, J-point elevation ,1 mm in leads containing negative T-waves (OR ¼ 227, 95% CI ¼ 12-1620, P , 0.001), TWI beyond lead V4 (OR ¼ 331; 95% CI ¼ 20-2752, P ¼ 0.001), and max TWI ≥5 mm (OR ¼ 10.95% CI ¼ 1.3 -100, P ¼ 0.03) remained independent predictors for HCM ( Table 2) . 
Comparison of electrocardiogram findings between healthy athletes and arrhythmogenic right ventricular cardiomyopathy patients
Electrocardiogram findings in healthy athletes and ARVC patients are shown in Table 3 . Compared with ARVC patients, athletes more frequently exhibited J-point elevation ≥1 mm in at least one anterior lead with a negative T-wave (80 vs. 2%, P , 0.001), ST-segment elevation ≥1 mm in at least one anterior lead with a negative T-wave (83 vs. 38%, P , 0.001), TWI confined to leads V1-V4 (71 vs. 45%, P , 0.001), and max TWI ≥5 mm (19 vs. 5%, P , 0.001). In contrast, ARVC patients more frequently exhibited TWI extending to the lateral and/or involving inferior leads (Figure 3) . At multiple regression analysis, after adjustment for age, gender, and ethnicity, J-point elevation ,1 mm in leads with negative T-waves (OR ¼ 569, 95% CI ¼ 38 -8545, P , 0.001) and TWI extending beyond lead V4 (OR ¼ 6.0; 95% CI ¼ 1.2 -37.8, P ¼ 0.03) remained independent predictors of ARVC ( Table 4) .
Electrocardiogram of athletes with cardiomyopathy
The ECG characteristics of the subgroups of patients who were diagnosed with either HCM or ARVC at pre-participation screening (affected athletes) are shown in Supplementary material online, Table S2 and S3. None of the 26 athletes with HCM (n ¼ 22 male; n ¼ 22 white) revealed TWI confined to V1 -V4. J-point elevation ≥1 mm in at least one anterior lead containing a negative T-wave was present in 3 of 22 (14%) white and in 3 of 4 (75%) black athletes with HCM. None of the 9 athletes with ARVC (all white males) revealed J-point elevation ≥1 mm in at least one anterior lead containing a negative T-wave, while 7 of 9 (78%) demonstrated negative T-waves confined to V1-V4. Anterior T-wave inversion in athlete's heart vs. cardiomyopathy 
Electrocardiogram diagnostic accuracy for cardiomyopathy
Comparing healthy athletes with both patients and athletes with cardiomyopathy (either HCM or ARVC), J-point elevation ,1 mm or TWI extending beyond V4 showed an overall sensitivity for cardiomyopathy of 100%, a specificity for athlete's heart of 55%, a positive predictive value of 0.03 and 0.42% for HCM and ARVC, respectively, and a negative predictive value of 100% for both HCM and ARVC ( Table 5 , see Supplementary material online, Table  S4 ). In a sub-analysis of ECG findings between healthy athletes and athletes affected by cardiomyopathy, the sensitivity and negative predictive value of combined ECG criteria for both HCM and ARVC were 100% (see Supplementary material online, Anterior T-wave inversion in athlete's heart vs. cardiomyopathy
Compared with J-point elevation ,1 mm, ST-segment elevation ,1 mm in combination with TWI extending beyond V4 showed a lower sensitivity and negative predictive value for cardiomyopathy while maintaining a similar specificity and positive predictive value for athlete's heart (Table 5 and Figure 4 ).
Inter-observer variability in electrocardiogram interpretation
There was excellent inter-observer agreement in the evaluation of J-point elevation ,1 mm and TWI extending beyond V4 translating to a k (measurement of agreement) of 0.97 (P , 0.001) and 1.0 (P , 0.001), respectively.
Discussion
The present study demonstrates that the combined evaluation of J-point elevation and TWI confined to lead V1-V4 allows more accurate differentiation between 'physiologic' and 'cardiomyopathic' TWI among individuals of both white and black ethnicity.
Differential diagnosis
Because TWI is one of the most striking ECG markers for HCM and ARVC, the presence of this repolarization abnormality on an athlete's ECG is considered a 'red-flag' sign requiring comprehensive evaluation. 1 -3,24,25 Often, this process entails expensive clinical investigation using a combination of imaging techniques, exercise tests, 24-h Holter monitoring, and, if feasible, genetic testing to exclude an underlying cardiomyopathy. However, TWI in V1 -V4 is also observed on the ECG of healthy athletes, particular those of Afro-Caribbean descent. 4, 10 The present study identified additional ECG parameters that can be used to allow discrimination between physiological (athlete's heart) and pathological (either HCM or ARVC) anterior TWI, independent of ethnicity.
Hypertrophic cardiomyopathy A previous study comparing the prevalence of anterior TWI in black athletes and black patients with HCM suggested that TWI limited to leads V1-V4 and associated with an upward ST-segment is likely to represent an ethnic variant of 'athlete's heart'. 4 The present study confirmed these findings demonstrating that, unlike healthy athletes, both patients and athletes with HCM usually exhibit TWI extending beyond V4. However, our study did not confirm the discriminating value of an upward ST-segment preceding TWI, given that it was detected in 40% of the overall HCM population compared with 83% of trained healthy athletes. Instead, we observed that the J-point amplitude preceding TWI provided the best accuracy for discriminating electrical manifestations of physiological adaptation from pathological anterior TWI: anterior TWI without J-point elevation (i.e. J point ,1 mm) showed a 92% sensitivity for HCM compared with 60% of TWI without ST-segment elevation, despite a similar specificity.
Arrhythmogenic right ventricular cardiomyopathy T-wave inversion in V1 -V4 is the most striking and frequent ECG marker of ARVC, which is the leading cause of SCD in white athletes in some parts of the world. 5 -8,23,26 Our study demonstrated that the extent and distribution of TWI across all precordial leads has limited value for distinguishing athlete's heart from ARVC. In fact, TWI extending beyond V4 showed a sensitivity for ARVC of only 55% in the overall cardiomyopathy cohort and of only 22% in the subgroup of athletes with ARVC. An upward ST-segment preceding TWI also appeared of limited value for differential diagnosis. Additionally, the current study reveals that J-point elevation preceding TWI was rarely observed in the total ARVC cohort and never found in the subgroup of athletes with ARVC; indeed, the absence of J-point elevation equated to a disease sensitivity of 98 and 100% in these two groups, respectively.
Hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy Although no single ECG criterion was accurate enough to differentiate athlete's heart from either HCM or ARVC, the combined analysis of the distribution of TWI across the precordial leads and the amplitude of J-point elevation preceding anterior TWI allowed identification of a cardiomyopathy in all affected individuals, regardless of the ethnicity. None of the patients or athletes with cardiomyopathy, either black or white, revealed both TWI limited to V4 and J-point elevation preceding TWI ( Figure 5 ). In comparison, the combined analysis of the extent of TWI across the precordial leads and ST-segment elevation preceding anterior TWI (i.e. the pattern utilized by the Seattle Criteria 2 ) showed a lower overall sensitivity for cardiomyopathies predominantly due to ARVC rather than to HCM, as 15% of ARVC patients revealed anterior TWI confined to V1 -V4 preceded by ST-segment (but without J point) elevation ( Table 5) .
The main goal of ECG interpretation in the context of preparticipation evaluation is to avoid any false-negatives, and in this regard, our ECG algorithm provided a 100% negative predictive value, which means 0% false-negative results. It is well known that the positive predictive value of broad-based ECG screening is very low because of the low prevalence of cardiomyopathy among athletes with ECG abnormalities. 1 In detail, the current practice of screening all athletes with anterior TWI translates into an estimated positive predictive value of 1 : 6667 for HCM and 1 : 500 for ARVC. Using our algorithm based on the combination of J-point amplitude and the distribution of TWI in athletes with anterior TWI, the overall specificity for athlete's heart was 55%, which implies that the number of false-positives (i.e. healthy athletes with anterior TWI) is reduced approximately by 50%. Accordingly, our algorithm allowed to improve the positive predictive values for cardiomyopathies of the ECG pattern of TWI in the athlete, by halving the number of athletes with anterior TWI who require further evaluation to detect 1 cardiomyopathy (from 6667 to 3333 for HCM and from 500 to 238 for ARVC), which is expected to result in a significant screening cost savings (see Supplementary material online, Tables S2 -S4).
Pathophysiology J-point elevation
Trained athletes commonly reveal the early repolarization pattern that arises from a physiologic increase of vagal tone and/or withdrawal of sympathetic activity. 27 -29 In our study, the vast majority of anterior TWI observed among healthy athletes of both ethnicities was preceded by J-point elevation, which suggested an underlying early repolarization mechanism ( Figure 4 ). This explains why the presence of J-point elevation preceding negative T-waves was the most accurate ECG marker for 'physiological' anterior TWI. Indeed, this marker was never observed among non-athlete patients with HCM or ARVC, although it was occasionally found among athletes with HCM, suggesting that signs of training-related 'physiological' early repolarization may co-exist with 'pathological' TWI caused by the underlying cardiomyopathy.
ST-segment elevation
We observed ST-segment elevation without J-point elevation in a sizeable proportion of patients with HCM and ARVC. This finding is in agreement with the results of previous studies showing a similar prevalence of ST-segment elevation in association with anterior TWI in these cardiomyopathies. 4, 7, 30 In addition, Sheikh et al. 16 reported a 63% prevalence of ST-segment elevation in highly trained athletes with HCM. Elevation of the ST-segment in these heart muscle diseases does not occur in the context of a physiological early repolarization but instead reflects underlying myocardial abnormalities such as ischaemic myocardial injury, myocardial degeneration and necrosis, or fibro-fatty myocardial replacement that may interfere with the normal transmission of electrical forces across the ventricular walls, resulting in ST-T repolarization abnormalities.
Extent of T-wave inversion
The limited overall accuracy of the extent of TWI alone for differentiating between athlete's heart and a cardiomyopathy is explained by the different ventricular involvement in HCM and ARVC. While HCM is predominately a 'LV' cardiomyopathy which most often exhibits TWI localized or extending to the lateral (V5-V6) and/or inferior LV leads (II/aVF/III), 19, 30 ARVC in its typical form is characterized by TWI confined to the RV leads (V1 -V3/V4). 7 Accordingly, the criterion of TWI limited to V1-V4 is useful in distinguishing anterior TWI representative of athlete's heart from the more diffuse TWI of HCM, but is less helpful for differentiating athlete's heart from ARVC.
Study limitations
Because of the disparities of age and gender between athletes and patients with cardiomyopathies, it remains to be proved whether our discriminating ECG algorithm would provide the same accuracy in differentiating athletes and patients with cardiomyopathies of the same age and gender. However, the sub-analysis of healthy young athletes (median age 21 years) vs. young athletes with cardiomyopathies (median age 23 years) confirmed the discriminating power of our ECG predictors. Furthermore, we cannot certain whether other confounding factors (unknown or difficult to adjust, including the different sources of HCM and ARVC patients/athletes) may have influenced the observed association between TWI patterns and diagnosis. The predominantly black athletic population of our study may not represent the ethnic composition of the general athletic population encountered in the European countries. However, our study focused on the subset of athletes who commonly exhibit anterior TWI, notably the black athletes. 12 Although athletes were subject to a systematic and comprehensive array of investigations to exclude an underlying cardiomyopathy, based on this cross sectional study, we cannot be certain about the possibility of such individuals developing overt features of a cardiomyopathy at a later date. 24, 31 Finally, our excellent sensitivity of ECG repolarization patterns for diagnosis of cardiomyopathies should not be generalized
Anterior T-wave inversion in athlete's heart vs. cardiomyopathy to the entire population of patients with HCM or ARVC, but according to the study design is only applicable to the subset of patients with anterior TWI.
